These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 33667781

  • 21. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL, Lockhart S, Callister C, Hoover K, Binswanger IA.
    J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
    [Abstract] [Full Text] [Related]

  • 22. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
    Thakrar AP, Uritsky TJ, Christopher C, Winston A, Ronning K, Sigueza AL, Caputo A, McFadden R, Olenik JM, Perrone J, Delgado MK, Lowenstein M, Compton P.
    Addict Sci Clin Pract; 2023 Feb 24; 18(1):13. PubMed ID: 36829242
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Barriers to retention in medications for opioid use disorder treatment in real-world practice.
    Villamil VI, Underwood N, Cremer LJ, Rooks-Peck CR, Jiang X, Guy GP.
    J Subst Use Addict Treat; 2024 May 24; 160():209310. PubMed ID: 38331319
    [Abstract] [Full Text] [Related]

  • 26. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM, Arnsten J, Olsen JP, Arias F, Cunningham CO, Rivera Mindt M.
    Addict Sci Clin Pract; 2021 Oct 24; 16(1):64. PubMed ID: 34689841
    [Abstract] [Full Text] [Related]

  • 27. METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.
    Huo S, Heil J, Salzman MS, Carroll G, Haroz R.
    J Emerg Med; 2023 Mar 24; 64(3):391-396. PubMed ID: 37019500
    [Abstract] [Full Text] [Related]

  • 28. Impact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder.
    Jaffe K, Patel S, Chen L, Slat S, Bohnert A, Lagisetty P.
    Subst Use Addctn J; 2024 Oct 24; 45(4):706-715. PubMed ID: 38828548
    [Abstract] [Full Text] [Related]

  • 29. Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration.
    Ching JH, Owens DK, Trafton JA, Goldhaber-Fiebert JD, Salomon JA.
    Addiction; 2021 Dec 24; 116(12):3494-3503. PubMed ID: 33999485
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections.
    Marks LR, Munigala S, Warren DK, Liss DB, Liang SY, Schwarz ES, Durkin MJ.
    J Infect Dis; 2020 Sep 02; 222(Suppl 5):S513-S520. PubMed ID: 32877547
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
    Dunn KE, Finan PH, Andrew Tompkins D, Strain EC.
    Addict Behav; 2018 Jan 02; 76():8-14. PubMed ID: 28735039
    [Abstract] [Full Text] [Related]

  • 39. Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder.
    Robin AM, Hersh AR, John C, Caughey AB.
    J Matern Fetal Neonatal Med; 2022 Dec 02; 35(25):4918-4926. PubMed ID: 33455473
    [Abstract] [Full Text] [Related]

  • 40. Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.
    De Aquino JP, Parida S, Avila-Quintero VJ, Flores J, Compton P, Hickey T, Gómez O, Sofuoglu M.
    Drug Alcohol Depend; 2021 Nov 01; 228():109097. PubMed ID: 34601272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.